✦ LIBER ✦

Intravesical Recombinant Tumor Necrosis Factor in the Treatment of Superficial Bladder Cancer: An Eastern Cooperative Oncology Group Study

✍ Scribed by Glazier, David B.; Bahnson, Robert R.; McLeod, David G.; von Roemeling, Reinhard W.; Messing, Edward M.; Ernstoff, Marc S.

Book ID: 123198487
Publisher: Lippincott Williams and Wilkins
Year: 1995
Tongue: English
Weight: 372 KB
Volume: 154
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)67228-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IS THERE A ROLE FOR RECOMBINANT TUMOR NE

IS THERE A ROLE FOR RECOMBINANT TUMOR NECROSIS FACTOR ALPHA IN THE INTRAVESICAL TREATMENT OF SUPERFICIAL BLADDER TUMORS?—A PHASE II STUDY

✍ V Serretta; B Piazza; C Pavone; S Piazza; M Pavone-Macaluso 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

The 4th study of prophylactic intravesic

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

✍ Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 397 KB

Phase II study of N-methylformamide, spi

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

✍ Ettinger, David S. ;Finkelstein, Dianne M. ;Donehower, Ross C. ;Chang, Alex Y. C 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

One hundred forty-four patients with non-small cell lung cancer, the majority (72%) of whom had received previous chemotherapy, were evaluable in this randomized phase II study of N-methylformamide (N-MF), spirogermanium, and 4-demethoxydaunorubicin. There were two partial responses, one each with s

Phase II study of N-methylformamide, spi

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Modified vincristine, doxorubicin, and d

Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group study

✍ William R. Friedenberg; Janet Anderson; Barbara C. Wolf; Peter A. Cassileth; Mar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

A randomized trial of megestrol acetate

A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer: A study of the Eastern Cooperative Oncology Group (E2185)

✍ Charles D. Cobau; Katrien Declercq; Donna Neuberg; James N. Ingle; Douglass C. T 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## BACKGROUND. Human breast cancer cells in vitro exhibit increased levels of progestin receptors (PgR) after brief exposure to physiologic concentrations of estrogens. Prior clinical studies have positively correlated the responsiveness of metastatic breast cancer to progestin therapy with the le